Atlas Arteria - Public Comps and Valuation Multiples

Atlas Arteria Overview

About Atlas Arteria

Atlas Arteria is a global toll-road investor created out of the reorganization of Macquarie Infrastructure Group in 2010. The firm's main asset is a 30.82% stake in Autoroutes Paris-Rhin-Rhone, or APRR. APRR owns concessions to toll more than 2,300 kilometers of motorways in eastern France, most ending late 2035. The firm also wholly owns the Dulles Greenway and 66.67% of the Chicago Skyway, both in the US.

Founded

2009

HQ

Employees

3.3K+

Website

atlasarteria.com

Sectors

Road Infrastructure

Financials

LTM Revenue $119M

LTM EBITDA $56.6M

EV

$5.9B

Valuation Multiples

Multiples.vc

Valuation Multiples for 15K+ Public Comps

Benchmark forward-looking revenue and EBITDA valuation multiples across generative AI, climate tech, semiconductors, online marketplaces, vertical SaaS and 220 more verticals.

Browse Valuation Multiples

Atlas Arteria Financials

As of August 2025, Atlas Arteria reported last 12-month revenue of $119M and EBITDA of $56.6M.

In the same period, Atlas Arteria generated $85.6M in LTM gross profit and $206M in net income.

See Atlas Arteria valuation multiples based on analyst estimates

Atlas Arteria P&L

In the most recent fiscal year, Atlas Arteria reported revenue of $95.0M and EBITDA of $291M.

Atlas Arteria expects next 12-month revenue of XXX and NTM EBITDA of XXX

See Atlas Arteria valuation multiples based on analyst estimates

	LTM	NTM	Last FY	FY 2025	FY 2026	FY 2027
Revenue	$119M	XXX	$95.0M	XXX	XXX	XXX
Gross Profit	$85.6M	XXX	$90.9M	XXX	XXX	XXX
Gross Margin	72%	XXX	96%	XXX	XXX	XXX
EBITDA	$56.6M	XXX	$291M	XXX	XXX	XXX
EBITDA Margin	47%	XXX	306%	XXX	XXX	XXX
EBIT	$22.2M	XXX	-$5.3M	XXX	XXX	XXX
EBIT Margin	19%	XXX	-6%	XXX	XXX	XXX
Net Profit	$206M	XXX	$220M	XXX	XXX	XXX
Net Margin	173%	XXX	232%	XXX	XXX	XXX
Net Debt	XXX	XXX	$963M	XXX	XXX	XXX

Financial data powered by Morningstar, Inc.

.seo-only-financials-wrapper { position: static; left: auto; width: auto; height: auto; overflow: visible; }

Financial performance metrics for Atlas Arteria including revenue, profitability, and margin analysis across different time periods. The company reported last twelve months revenue of $119M. EBITDA for the last twelve months was $56.6M. In the most recent fiscal year, Atlas Arteria achieved $95.0M in revenue and $291M in EBITDA.
Financial Metric	Last Twelve Months (LTM)	Next Twelve Months (NTM)	Most Recent Fiscal Year	Current Fiscal Year (2025)	Next Fiscal Year (2026)	Two Years Forward (2027)
Total Revenue	$119M	Analyst estimates available to subscribers	$95.0M	Analyst estimates available to subscribers	Analyst estimates available to subscribers	Analyst estimates available to subscribers
Gross Profit	$85.6M	Analyst estimates available to subscribers	$90.9M	Analyst estimates available to subscribers	Analyst estimates available to subscribers	Analyst estimates available to subscribers
Gross Profit Margin	71.8% gross margin	Analyst estimates available to subscribers	95.7% gross profit margin	Analyst estimates available to subscribers	Analyst estimates available to subscribers	Analyst estimates available to subscribers
EBITDA (Earnings Before Interest, Taxes, Depreciation, Amortization)	$56.6M	Analyst estimates available to subscribers	$291M	Analyst estimates available to subscribers	Analyst estimates available to subscribers	Analyst estimates available to subscribers
EBITDA Margin	47.4% EBITDA margin	Analyst estimates available to subscribers	306.1% EBITDA margin	Analyst estimates available to subscribers	Analyst estimates available to subscribers	Analyst estimates available to subscribers
EBIT (Earnings Before Interest and Taxes)	$22.2M	Analyst estimates available to subscribers	-$5.3M	Analyst estimates available to subscribers	Analyst estimates available to subscribers	Analyst estimates available to subscribers
EBIT Margin	18.7% EBIT margin	Analyst estimates available to subscribers	-5.6% EBIT margin	Analyst estimates available to subscribers	Analyst estimates available to subscribers	Analyst estimates available to subscribers
Net Income (Net Profit)	$206M	Analyst estimates available to subscribers	$220M	Analyst estimates available to subscribers	Analyst estimates available to subscribers	Analyst estimates available to subscribers
Net Profit Margin	172.7% net profit margin	Analyst estimates available to subscribers	231.7% net profit margin	Analyst estimates available to subscribers	Analyst estimates available to subscribers	Analyst estimates available to subscribers
Net Debt Position	Detailed debt information available to subscribers	Detailed debt information available to subscribers	$963M	Detailed debt information available to subscribers	Detailed debt information available to subscribers	Detailed debt information available to subscribers

Financial Performance Summary for Atlas Arteria

This financial data table provides comprehensive performance metrics for Atlas Arteria, a company based in Australia. The metrics include revenue, profitability measures, and operational efficiency indicators across multiple time periods.

Recent Performance Highlights

Atlas Arteria generated $119M in revenue over the last twelve months.
The company achieved $56.6M in EBITDA over the last twelve months.
Gross profit for the last twelve months was $85.6M.
Net income over the last twelve months reached $206M.

Fiscal Year Performance

In the most recent fiscal year, Atlas Arteria reported $95.0M in total revenue.
Fiscal year EBITDA was $291M.
The company maintained a gross profit margin of 95.7% in the most recent fiscal year.
EBITDA margin for the fiscal year was 306.1%.
Net profit margin reached 231.7% in the most recent fiscal year.

This financial data is sourced from Morningstar, Inc. and represents the most recent available information for Atlas Arteria. Forward-looking estimates and detailed financial projections are available through our premium subscription service.

Atlas Arteria Stock Performance

Atlas Arteria has current market cap of AUD 7.6B (or $5.0B), and EV of AUD 9.1B (or $5.9B).

Market Cap Evolution

Atlas Arteria Stock Data

As of September 15, 2025, Atlas Arteria's stock price is AUD 5 (or $3).

See Atlas Arteria trading valuation data

EV	Market Cap	Price 1D	Price 1M	Price 3M	Price 12M	EPS
$5.9B	$5.0B	XXX	XXX	XXX	XXX	$0.14

Benchmark Trading Valuation Multiples by Industry

Sign up to access valuation multiples like growth-adjusted P/E, next 12-month EV/Revenue, EBITDA multiples by industry and many more

Start Free Trial

Atlas Arteria Valuation Multiples

Atlas Arteria's trades at 62.4x EV/Revenue multiple, and 20.4x EV/EBITDA.

See valuation multiples for Atlas Arteria and 15K+ public comps

Atlas Arteria Financial Valuation Multiples

As of September 15, 2025, Atlas Arteria has market cap of $5.0B and EV of $5.9B.

Equity research analysts estimate Atlas Arteria's 2025E EV/Revenue multiple at XXX and 2025E EV/EBITDA multiple at XXX

Atlas Arteria has a P/E ratio of 24.3x.

	LTM	NTM	Last FY	FY 2025	FY 2026	FY 2027
Market cap (current)	$5.0B	XXX	$5.0B	XXX	XXX	XXX
EV (current)	$5.9B	XXX	$5.9B	XXX	XXX	XXX
EV/Revenue	49.8x	XXX	62.4x	XXX	XXX	XXX
EV/EBITDA	104.9x	XXX	20.4x	XXX	XXX	XXX
EV/EBIT	266.7x	XXX	-1117.6x	XXX	XXX	XXX
EV/Gross Profit	69.3x	XXX	n/a	XXX	XXX	XXX
P/E	24.3x	XXX	22.8x	XXX	XXX	XXX
EV/FCF	17.9x	XXX	98.3x	XXX	XXX	XXX

Valuation data powered by FactSet, Inc. and Morningstar, Inc.

Get Atlas Arteria Valuation Multiples

Access all public comps and forward-looking valuation multiples like EV/Revenue in 2025, based on equity research analyst estimates.

Start Free Trial

Atlas Arteria Margins & Growth Rates

Atlas Arteria's last 12 month revenue growth is 11%

Atlas Arteria's revenue per employee in the last FY averaged $29K, while opex per employee averaged $29K for the same period.

Atlas Arteria's rule of 40 is 331% (metric relevant for SaaS companies only, counted as combined revenue growth rate and EBITDA margin).

Atlas Arteria's rule of X is 75% (created by Bessemer, rule of X is another metric relevant for SaaS companies only, ~1.5x stronger vs. the traditional Rule of 40, counted as revenue growth rate multiplied by 2.5 plus EBITDA margin).

See operational valuation multiples for Atlas Arteria and other 15K+ public comps

Atlas Arteria Operational Valuation Multiples

	LTM	NTM	Last FY	FY 2025	FY 2026	FY 2027
Revenue Growth	11%	XXX	19%	XXX	XXX	XXX
EBITDA Margin	47%	XXX	306%	XXX	XXX	XXX
EBITDA Growth	1%	XXX	-55%	XXX	XXX	XXX
Rule of 40	331%	XXX	317%	XXX	XXX	XXX
Bessemer Rule of X	XXX	XXX	75%	XXX	XXX	XXX
Revenue per Employee	XXX	XXX	$29K	XXX	XXX	XXX
Opex per Employee	XXX	XXX	$29K	XXX	XXX	XXX
S&M Expenses to Revenue	XXX	XXX	n/a	XXX	XXX	XXX
G&A Expenses to Revenue	XXX	XXX	n/a	XXX	XXX	XXX
R&D Expenses to Revenue	XXX	XXX	n/a	XXX	XXX	XXX
Opex to Revenue	XXX	XXX	101%	XXX	XXX	XXX

Valuation data powered by FactSet, Inc. and Morningstar, Inc.

Valuation Multiples Across 220+ Verticals

Benchmark public comps and private revenue and EBITDA valuation multiples across GRC software, cloud infrastructure, DevOps, online marketplaces and so much more!

Digital Therapeutics

Pharma Analytics

Private Equity

ERP Software

Developer Tools

Consumer SaaS

Streaming Platforms

Explore Valuation Multiples by Industry

Start Free Trial